Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Comment
Editorial

The Guardian view on cancer survival rates: there is good news about healthcare amid the gloom

mRNA cancer immunotherapy for non-small cell lung cancer (NSCLC) - known as BNT116 - from Keenjee Nama, senior research nurse at the University College London Hospital LungCancer. Photo credit should read: Aaron Chown/PA Wire
‘One in two people in the UK will get a cancer diagnosis at some point in their lives and cancer care is a high priority for voters.’ Photograph: Aaron Chown/PA

New analysis from Cancer Research UK, revealing a 29% drop in the rate of people dying from cancer compared with 40 years ago, is a vital counterpoint to grim health headlines about the UK’s outcomes falling behind those of other countries, and the NHS missing its own cancer targets. Prof Chris Whitty, the chief medical officer for England, made a related point in a recent lecture. Stand back from the day to day, he said, and the extraordinary leaps forward enabled by vaccinations and other advances in treatment and public health come into focus.

This longer view is not a cause for complacency or inaction. England’s latest cancer plan, launched last month, highlighted shocking lapses including lengthy waits for treatment and a failure to tackle inequalities in cancer mortality dating back 15 years. Last year, analysis by the Guardian found that about three-quarters of NHS trusts were failing to reach standards relating to diagnosis and treatment.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.